扩展的组织病理学评估对转移性皮肤鳞状细胞癌的预后价值有限:两项全国性巢式病例对照研究的启示
该研究基于荷兰癌症登记处和全国病理登记处超过10年随访数据(n=19 120例患者),开展两项巢式病例对照研究,评估精细组织病理学变量与皮肤鳞状细胞癌(CSCC)转移的关联及其相对于常规变量的附加价值。第一项人群基础集(195例转移病例匹配195例非转移对照)多变量分析显示精细组织病理学变量与转移无显著关联;第二项风险匹配集(250例匹配250例对照)中,广泛(OR 0.28,95%CI 0.09-0.87)和中度(OR 0.20,95%CI 0.07-0.56)日光性弹性纤维变性(solar elastosis)与转移呈负相关。结论认为多数精细组织病理学变量在常规危险因素之外可能不提供额外预后价值。
要点
- 多数精细组织病理学变量(形态学亚型、肿瘤出芽、核分裂等)未显示与CSCC转移显著相关。
- 在风险匹配集中,广泛和中度日光性弹性纤维变性均与转移风险降低相关。
- 常规临床病理变量(如浸润深度、分化程度)仍是CSCC转移风险评估的主要依据。
核心结论
- 多数精细组织病理学变量在常规危险因素之外可能不提供额外的CSCC转移预后价值。
- 日光性弹性纤维变性(solar elastosis)与转移呈负相关,值得进一步研究。
研究设计与样本
- 两项巢式病例对照研究,使用荷兰癌症登记处和全国病理登记处数据,随访超过10年,共n=19 120例患者。
- 第一项为人群基础集:195例转移性CSCC病例按随访时间匹配195例非转移对照。
- 第二项为风险匹配集:250例病例按计算转移风险匹配250例对照。
- 病理学家审阅所有原发CSCC,评估精细变量包括形态学亚型、日光性弹性纤维变性、瘤周浸润、肿瘤出芽和核分裂。
- 分析采用条件logistic回归。
主要发现
- 人群基础集中,多变量分析显示精细组织病理学变量与转移无显著关联。
- 风险匹配集中,广泛日光性弹性纤维变性(OR 0.28,95%CI 0.09-0.87)与转移负相关。
- 风险匹配集中,中度日光性弹性纤维变性(OR 0.20,95%CI 0.07-0.56)与转移负相关。
临床怎么用
- 常规临床病理变量(如浸润深度、分化程度)仍是CSCC转移风险分层的主要依据。
- 不建议常规依赖精细组织病理学变量(如肿瘤出芽、核分裂)进行转移风险预测。
- 瘤周日光性弹性纤维变性程度可能作为潜在负相关指标,但需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although multiple refined histopathological variables have been proposed to improve risk stratification of patients with cutaneous squamous cell carcinoma (CSCC), evidence of their added value over conventional clinicopathological variables such as depth of invasion or differentiation grade is limited. OBJECTIVES: To evaluate the association between refined histopathological variables and metastasis in CSCC and their value relative to routinely available variables. METHODS: We conducted two nested case-control (NCC) studies using data from the Netherlands Cancer Registry and nationwide pathology registry with over 10 years of follow-up (n = 19 120 patients). The first NCC study included a population-based set of 195 primary CSCCs of metastatic cases matched to 195 primary CSCCs of nonmetastatic controls based on follow-up time. The second NCC study included a metastatic risk-matched set, matching 250 cases with 250 controls based on calculated metastatic risk. Pathologists reviewed all primary CSCCs, including the refined variables: morphological subtype, solar elastosis, peritumoral infiltrate, tumour budding and mitosis. Analyses were conducted using conditional logistic regression. RESULTS: In the population-based set, multivariable analyses showed no significant associations between refined histopathological variables and metastasis. In the risk-matched set, extensive [odds ratio (OR) 0.28, 95% confidence interval (CI) 0.09-0.87] and moderate (OR 0.20, 95% CI 0.07-0.56) solar elastosis were negatively associated with metastasis. CONCLUSIONS: Most refined histopathological variables may not provide additional prognostic value beyond conventional risk factors for metastasis in patients with CSCC. The observed inverse association between solar elastosis and metastasis warrants further research. Cutaneous squamous cell carcinoma (CSCC) is a type of skin cancer. Most cases are low-risk and treatable. Still, in a small percentage of people (around 2–5%), the cancer can spread to other parts of the body and become more dangerous. It is important to try and predict which CSCC tumours are more likely to spread. Then we can decide how to treat the cancer. Our study was done in the Netherlands, using a national dataset of CSCC cases. We looked at whether analysing specific microscopic features of the tumour could more accurately predict the risk of spread. We found that most refined microscopic features did not help predict which tumours would spread. Interestingly, we also found that people with less sun-damaged skin around their tumours were more likely to have their cancer spread. This might mean that tumours triggered by something other than sun exposure alone (e.g. long-term skin conditions such as chronic wounds) could be more likely to spread. In conclusion, the knowledge from this study will help to identify people at high risk of CSCC spreading, and provides directions for future research.
引用
- Steijlen OFM, Rentroia-Pacheco B, Tokez S, et al. Expanding histopathological assessment may provide limited prognostic value for metastatic cutaneous squamous cell carcinoma: insights from two nationwide nested case-control studies. Br J Dermatol. 2026. PMID: 42276591. doi:10.1093/bjd/ljag227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。